{"id":20135483,"updated":"2025-11-14T07:24:21Z","additionalIndexing":"15;2841;Bundesamt für Gesundheit;pharmazeutische Industrie;Arzneikosten;Preisunterschied;Forschungspolitik;Forschungsförderung;medizinische Forschung;Wirtschaftsstandort Schweiz;Medikament;Wechselkurs","affairType":{"abbreviation":"Fra.","id":14,"name":"Fragestunde. Frage"},"author":{"councillor":{"code":2748,"gender":"f","id":4040,"name":"Schneider-Schneiter Elisabeth","officialDenomination":"Schneider-Schneiter"},"faction":{"abbreviation":"Fraktion CE","code":"M-E","id":3,"name":"Fraktion CVP-EVP"},"type":"author"},"deposit":{"council":{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N"},"date":"2013-11-27T00:00:00Z","legislativePeriod":49,"session":"4911"},"descriptors":[{"key":"L04K16020204","name":"Forschungsförderung","type":1},{"key":"L03K160202","name":"Forschungspolitik","type":1},{"key":"L03K010503","name":"pharmazeutische Industrie","type":1},{"key":"L05K0704030111","name":"Wirtschaftsstandort Schweiz","type":1},{"key":"L05K0105050101","name":"Arzneikosten","type":1},{"key":"L05K0105030102","name":"Medikament","type":2},{"key":"L04K11030304","name":"Wechselkurs","type":2},{"key":"L04K11050311","name":"Preisunterschied","type":2},{"key":"L04K08040103","name":"Bundesamt für Gesundheit","type":2},{"key":"L04K01050512","name":"medizinische Forschung","type":2}],"drafts":[{"consultation":{"resolutions":[]},"federalCouncilProposal":{},"index":0,"links":[],"preConsultations":[],"references":[],"relatedDepartments":[{"abbreviation":"EDI","id":4,"name":"Departement des Innern","leading":true}],"states":[{"date":"\/Date(1385506800000+0100)\/","id":24,"name":"Im Rat noch nicht behandelt"},{"date":"\/Date(1385938800000+0100)\/","id":229,"name":"Erledigt"}],"texts":[]}],"language":"de","relatedAffairs":[],"roles":[{"councillor":{"code":2748,"gender":"f","id":4040,"name":"Schneider-Schneiter Elisabeth","officialDenomination":"Schneider-Schneiter"},"faction":{"abbreviation":"Fraktion CE","code":"M-E","id":3,"name":"Fraktion CVP-EVP"},"type":"author"}],"shortId":"13.5483","state":{"id":229,"name":"Erledigt","doneKey":"0","newKey":0},"texts":[{"type":{"id":5,"name":"Eingereichter Text"},"value":"<p>- Wie steht es mit der Ausarbeitung des Masterplans für die Stärkung des Forschungs- und Pharmastandortes Schweiz?<\/p><p>- Treibt der Bundesrat diesen mit hoher Priorität voran?<\/p><p>- Wann legt er den Masterplan zuhanden des Parlamentes vor?<\/p>"},{"type":{"id":1,"name":"Titel des Geschäftes"},"value":"Stärkung des Forschungs- und Pharmastandortes Schweiz"}],"title":"Stärkung des Forschungs- und Pharmastandortes Schweiz"}